Navigation Links
QMed, Inc. Announces $750,000 in Financing and Settlement with DAKOTACARE
Date:3/20/2008

ny. The investors will be entitled, in the case of a sale or exchange of all or, under certain circumstances, a majority of the outstanding shares, or an issuance of new shares constituting a majority of the outstanding shares, or a sale of all or substantially all of the Company's assets, to receive, either from the Company or by virtue of the transaction itself, the consideration payable in connection with the transaction on the shares underlying their warrants, or if no consideration is payable with respect to the shares in the transaction (such as in a new issuance of shares or in certain asset sale transactions), the market value of the shares after giving effect to the transaction, in each case net of the exercise price of the warrants. Pursuant to the transaction, the Investors have the right to have two observers present at Board Meetings.

The staff at Nasdaq has informed the Company orally that they are of the opinion that, as Mr. Gargana was a director of QMed (Mr. Gargana resigned as a director on March 18, 2008), this transaction would violate a NASDAQ rule unless shareholder approval were obtained, because the issuance of warrants in the transaction may be deemed compensation. Because of QMed's need for working capital, and because the Company is already in receipt of delisting letters from NASDAQ, QMed has decided to proceed with the transaction without seeking shareholder approval. As a result, the Company's shares may be delisted by Nasdaq. The Company has not yet determined whether it will appeal Nasdaq's or its staff's determination.

This transaction does not involve the assets or operations of QMedCare of New Jersey, Inc., and its HMO operations. The Company and QMedCare of New Jersey, Inc. continue to work with the New Jersey Department of Banking and Insurance on the orderly wind down of operations of the New Jersey HMO.

In an unrelated matter, the Company's LakeShore Captive Insurance subsidiary received approval from the S
'/>"/>

SOURCE QMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. QMed, Inc. Announces the Termination of Its New Jersey Special Needs Plan
2. QMed, Inc. Receives NASDAQ Letter
3. QMed, Inc. Retains Lazard Middle Market
4. QMed, Inc. Reports Third Quarter Results
5. QMed, Inc. Extends Agreement & Receives $550,000 Performance Bonus
6. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
7. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
8. Perrigo Company Announces Launch of Clobetasol Propionate Foam
9. Batesville Holdings Announces New Board of Directors in Preparation for March 31 Spin-Off from Hillenbrand Industries
10. ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic Zapper Said to Destroy Molluscum Contagiosum Pathogen
11. Lifeway Foods Announces Expanded Distribution and Growing Success of ProBugs(TM) Organic Kefir for Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Village, CA (PRWEB) September 23, 2014 ... Dental Office is now offering complimentary oral sedation with ... 15 percent of Americans suffer from dental anxiety or ... uncomfortable for patients; they can also keep patients from ... anxiety or phobia in Westlake Village and surrounding areas ...
(Date:9/23/2014)... YORK, NY (PRWEB) September 23, 2014 ... best innovators in the pharmaceutical industry with their annual ... bestowed at a gala banquet at Gotham Hall in ... and brand managers representing top talent and brands. ... celebrate its accomplishments,” says Anna Stashower, CEO and Publisher ...
(Date:9/23/2014)... Gurnee, IL (PRWEB) September 23, 2014 ... lighting solutions, has expanded its MedMaster™ M4 product ... The luminaire extends the M4 product line – ... green LED options – providing more flexibility when ... of the MedMaster M4 Series include:, ...
(Date:9/23/2014)... 2014 The U.S. Pharmacopeial Convention (USP) ... Health Organization (WHO) regarding the assignment of Biological Qualifiers ... by the Expert Group of the Programme of International ... to the naming of all biologicals that is consistent ... assessment of these drugs. , Hence, USP supports ...
(Date:9/23/2014)... N.J. (PRWEB) September 23, 2014 ... provider of advanced delivery technologies and development ... products, today announced that it had reached ... privately held biopharmaceutical company, Cingulate Therapeutics (CTx), ... of new prescription pharmaceutical products for the ...
Breaking Medicine News(10 mins):Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 2Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 3Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 2Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 3Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 4Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 5Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 6Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 3Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2Health News:Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments 2Health News:Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments 3
... , TUESDAY, March 22 (HealthDay News) -- The death ... and were in remission two years after treatment was similar ... study shows. Italian researchers collected data on 832 patients ... and found that 20 patients died during the follow-up period. ...
... HealthDay Reporter , TUESDAY, March 22 (HealthDay News) -- ... on the rise in the United States despite research that ... say. Fibrates are often prescribed to people with low ... triglycerides, a harmful form of fat circulating in the blood, ...
... , TUESDAY, March 22 (HealthDay News) -- A low-cost ... of 400 seemingly healthy children and teens in a pilot ... screen all school-aged children for heart conditions that can lead ... Children,s Hospital of Philadelphia said in a hospital news release. ...
... , TUESDAY, March 22 (HealthDay News) -- Depression can worsen ... South Korean researchers used X-rays to assess the severity ... and older. The patients were also evaluated for the severity ... of pain were higher in patients whose X-rays showed greater ...
... and welfare reforms, and their use of ,nudge, theory, hark ... of the nineteenth century, according to studies by a University ... in the Lancet . Dr Kim Price,s article ... his second in the Lancet within a year drawing parallels ...
... researchers find when women explore their feelings about being or ... humorous. Findings from the project entitled ,Look at me! Images ... feelings about images of ageing. These findings are presented in ... April. Ageing is undoubtedly about the body, and pressure ...
Cached Medicine News:Health News:Leukemia Patients Taking Gleevec Achieve 'Normal' Death Rate 2Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 2Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 3Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 4Health News:Screening Seems to Catch Dangerous Heart Condition in Kids 2Health News:Depression May Boost Arthritis Pain 2Health News:Report indicates that 'new' welfare reforms hark back to Victorians 2Health News:Look at me! 2Health News:Look at me! 3Health News:Look at me! 4
(Date:9/22/2014)... 2014 ... eTMF im Jahr 2015 verdoppeln werden ... klinischen Versuchsreihen, die zunehmenden Anforderungen der Gesundheitsbehörden ... mit Informationen über ihre Versuchsreihen (Trial Master ... Die bisher größte TMF-Umfrage in der ...
(Date:9/22/2014)... Sept. 22, 2014 Levi & Korsinsky is ... or "the Company") (NasdaqGS: SIAL ) for ... state law in connection with the sale of the ... here to learn more about the investigation: http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199 ... obligation to you. Under the terms of ...
(Date:9/22/2014)... 2014 Avanir Pharmaceuticals, Inc. (NASDAQ: ... sell $200 million of its common stock in an ... BofA Merrill Lynch are acting as joint book-running managers ... 30-day option to purchase additional shares of its common ... the offering are being sold by Avanir.  The offering ...
Breaking Medicine Technology:Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 2Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 3Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 4Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 5SIGMA-ALDRICH INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Sigma-Aldrich Corporation In Connection with the Sale of the Company to Merck -- SIAL 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
... N.J., April 6, 2011 Columbia Laboratories, Inc. (Nasdaq: ... WPI ), today announced the publication of ... version of Ultrasound in Obstetrics & Gynecology , ... Ultrasound in Obstetrics & Gynecology. The ...
... NEW YORK, April 6, 2011 Academy Award-winning ... battle with throat cancer, is urging Americans to get screened ... Cancer Awareness Week (OHANCAW), being held nationwide May 8-14 . ... world will offer free oral, head and neck cancer screenings ...
Cached Medicine Technology:Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 2Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 3Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 4Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 5Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 6Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 7Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 8Michael Douglas, Honored Film Star and Throat Cancer Survivor, Encourages Public to Attend Free Local Screenings During Oral, Head & Neck Cancer Awareness Week 2Michael Douglas, Honored Film Star and Throat Cancer Survivor, Encourages Public to Attend Free Local Screenings During Oral, Head & Neck Cancer Awareness Week 3Michael Douglas, Honored Film Star and Throat Cancer Survivor, Encourages Public to Attend Free Local Screenings During Oral, Head & Neck Cancer Awareness Week 4
Ribbon malleable, general purpose retractor....
The Wire Cutters are designed to cut Kirschner wires up to 2.5 mm diameter easily and smoothly. They are particularly useful for external fixation applications. The Wire Cutters shear fixation wires ...
The osteotome shafts are manufactured with stainless steel and are available both straight and curved in 1/4" and 1/2" sizes....
... Pulse CDC Compact Cardiac Digital Camera is a ... open, patient-friendly gantry, and provides full sized fields ... into your clinic you need a flexible system ... Find out how the Pulse reduces the ...
Medicine Products: